N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane

DB02979ExperimentalSmall molecule

N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane: Overview.

Mechanism: Pharmacologically active on Nitric oxide synthase 3
Curator reviewed
Formula / weight: C₁₈H₃₈N₄S₂ · 374.651 g/mol (avg)

Resolves to

Compound

Structure

InChIKeyIOKDMHHZKWLWKO-UHFFFAOYSA-NSMILESCS\C(N)=N\CCCCCCCCCCCCCC\N=C(/N)SC

Targets

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.